Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00217087 · ClinicalTrials.gov registry record · Phase 2
Endoscopic Therapy of Early Cancer in Barretts Esophagus
A Phase 2 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 2
- Development phase
- 73
- Enrollment target
NCT00217087: Completed Phase 2 study, sponsored by Mayo Clinic.
NCT00217087 is a Phase 2 study that has completed, run by Mayo Clinic. The registered enrollment target is 73 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00217087, a Phase 2 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 73 participants
- Enrollment target
Study Summary
This study is being done to see if treatment for esophageal cancer can be done using endoscopy for patients ineligible for surgical or radiological therapy. The standard method of treating this type of cancer is surgical removal of the esophagus. The study will determine if removing just the cancer with endoscopy is enough treatment or if the addition of another treatment called photodynamic therapy (treatment with a red light and a drug called sodium porfimer) is needed.
Interventions
- PROCEDURE Endoscopic Mucosal Resection
- PROCEDURE Photodynamic Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2005-09 |
| Est. Completion | 2012-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00217087
The ClinicalTrials.gov registry entry for NCT00217087 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Endoscopic Mucosal Resection is the first listed.
NCT00217087 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00217087 about?
NCT00217087 is a clinical study titled "Endoscopic Therapy of Early Cancer in Barretts Esophagus". This study is being done to see if treatment for esophageal cancer can be done using endoscopy for patients ineligible for surgical or radiological therapy. The standard method of treating this type of cancer is surgical removal of the esophagus. The study will determine if removing just the cancer ...
What is the current status of trial NCT00217087?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 73 participants. The study started on 2005-09. Estimated completion is 2012-06.
What interventions are being tested in trial NCT00217087?
The interventions under investigation include: Endoscopic Mucosal Resection (PROCEDURE), Photodynamic Therapy (PROCEDURE).
Who is sponsoring clinical trial NCT00217087?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.